Navigation Links
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Date:11/29/2007

ABBOTT PARK, Ill., Nov. 29 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT)announced today that the Circulatory System Devices Advisory Panel to the U.S. Food and Drug Administration (FDA) recommended approval for the XIENCE(TM) V Everolimus Eluting Coronary Stent System. XIENCE V is a next-generation drug eluting stent intended for use in the treatment of coronary artery disease.

The FDA advisory committee voted to recommend the XIENCE V stent system for approval with conditions related to post-marketing study requirements and language related to dual antiplatelet therapy. The FDA is not required to, but usually follows the recommendations of its advisory committees.

"The clinical and angiographic benefits of the XIENCE V stent compared to the most widely used drug eluting stent available in the U.S. have been consistent and significant across the SPIRIT trials," said Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York and principal investigator of the SPIRIT III clinical trial. "The robust body of safety and efficacy data support approval of XIENCE V as an important new technology that will enhance the lives of millions of patients with heart disease."

Abbott filed its Premarket Approval (PMA) submission for XIENCE V with the FDA on June 1, 2007. The PMA for XIENCE V is the first to include data demonstrating superiority of one drug eluting stent over another in the primary endpoint of in-segment late loss in a randomized controlled head-to-head trial with a market leading product.

"The outcome of today's advisory committee meeting is very encouraging," said John M. Capek, Ph.D., executive vice president, Medical Products, Abbott. "We look forward to bringing this important new treatment for coronary artery disease to physicians and patients in the U.S."

XIENCE V was launched in Europe and other international markets in 2006. XIENCE V is currently an investigational
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Syngenta lawsuits are now being investigated by Wright ... that have allegedly incurred significant financial damages due to ... Duracade, genetically modified (GMO) corn seed products ... According to a report from Bloomberg News, Syngenta’s actions ... Because China is the third-largest American corn importer, Syngenta ...
(Date:11/22/2014)... Greenville, SC (PRWEB) November 23, 2014 ... back to their communities. AlignLife experience rapid growth in ... upon a very unique opportunity. AlignLife of Simpsonville ... area AlignLife offices for their first annual Toy Drive. ... local charity they would support with this year's toy ...
(Date:11/22/2014)... UWDress.com, a successful wedding dress shop, has released its new ... to prepare for the wedding season. All of them are ... UWDress.com is a reliable company that has many years of ... -- formal wedding guest attire. This new collection comes in ... princess. As one of the leading companies in the wedding ...
(Date:11/22/2014)... November 23, 2014 Today, Dylan Queen, ... new collection of wedding dresses; the business offers a ... related accessories for ladies worldwide, allowing them to create ... of the company, this new collection of chic wedding ... Moreover, they are offered at discounted rates now. Dylan ...
(Date:11/22/2014)... In order to provide better services, LunaDress has updated ... The business knows that a suitable cocktail party dress is ... Now, the party dresses supplier’s high quality items are offered ... company in fashion industry, LunaDress understands that it is not ... it always raises the professional level and innovation ability. The ...
Breaking Medicine News(10 mins):Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2
... Foundation announces that The 2011 Estabrook Lecture will be ... Center, 1199 Pleasant Valley Way in West Orange, New ... "Clinical Virtual Reality: A Brief Review of the Future", ... PhD, the Associate Director of the Institute for Creative ...
... (HealthDay News) -- Patients hospitalized for autoimmune disorders, like rheumatoid ... for a life-threatening pulmonary embolism, a clot in a main ... online Nov. 25 in The Lancet , researchers warned ... patients admitted to the hospital for autoimmune diseases. , , ...
... Calif. Neuroscientists at Stanford University School of Medicine ... brain cells by studying brainlike spheres grown in an ... cells from patients with Timothy syndrome, a rare genetic ... penetrant forms of autism: In other words, most people ...
... News) -- The sudden return to a normal routine after ... into a funk, but an expert outlines ways you can ... "A large part of happiness is anticipation. Thanksgiving, Christmas, Hanukkah, ... joy we look forward to for weeks. While the celebration ...
... The holiday season can be a challenge for people with ... they can do to protect themselves, allergists say. Food ... such allergens as wheat, soy, dairy and nuts, the experts ... of Allergy, Asthma and Immunology (ACAAI). For example, self-basting ...
... EAST LANSING, Mich. An inexpensive drug that treats ... of natural and man-made chemicals from stimulating the growth ... study by a Michigan State University researcher. The ... from South Korea,s Seoul National University, provides biological evidence ...
Cached Medicine News:Health News:Autoimmune Woes May Raise Risk for Lung Clots 2Health News:Scientists identify defect in brain cell channel that may cause autism-like syndrome 2Health News:Scientists identify defect in brain cell channel that may cause autism-like syndrome 3Health News:Scientists identify defect in brain cell channel that may cause autism-like syndrome 4Health News:How to Extend Holiday Cheer 2Health News:Allergy Sufferers Should Prepare for Holiday Triggers 2Health News:Diabetes drug shows promise in reducing risk of cancer 2
(Date:11/21/2014)... -- Alere Inc. (NYSE: ALR ), a global ... Cunningham as Vice President, Investor Relations. In this ... communications with the investment community. "As we ... increase shareholder value, it is critical that we effectively ... Executive Officer. "We are delighted that Juliet Cunningham ...
(Date:11/21/2014)... SAN DIEGO , Nov. 21, 2014 /PRNewswire/ ... TNDM ), a medical device company and ... today announced a partnership with Tidepool, a non-profit ... an open source software platform that increases diabetes ... the Tidepool Platform, which is currently under development, ...
(Date:11/21/2014)... SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ ... industrial hemp containing low THC, announces they are now ... is comparable to Charlotte,s Web type strains grown in ... symptoms from other neurological disorders, such as Parkinson,s, MS, ... waiting for US laws to pass, because imported CBD ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... The Targis® System uses Cooled ... to deliver precisely targeted microwave ... tissue creating coagulative necrosis for ... feedback system continually monitors urethral ...
Complete digital pulse oximetryanytime, anywhere, any patient....
Biopsy forceps...
Incontinence Pessaries...
Medicine Products: